Background: Centaurea aegyptiaca L (Asteraceae), is one of the most attractive plants growing wildly in Sinai, and is not well investigated for its phytochemical constituents. This study represents the first in-depth characterization of the phenolic profile of the aerial parts of C. aegyptiaca methanolic extract utilizing liquid chromatography (LC) combined with electrospray ionization (ESI) tandem mass spectrometry (MS/MS). Material and Methods: Phenolic profile was researched utilizing LC-HRESI-MS-MS. Assessment of cytotoxic activity against four human cancer cell lines (Hep-G2; hepatocellular carcinoma cells, MCF-7; breast adenocarcinoma cells, and HCT-116; colon carcinoma and HELA; cervical carcinoma cells) was performed using 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. Antiviral activity was surveyed utilizing cytopathic effect inhibition assay. Results: A total of sixty-one compounds were tentatively distinguished (twenty-one phenolic acids and their derivatives, thirty-one flavonols and nine flavones) in the negative and positive modes. Centaurea aegyptiaca demonstrated outstanding results against Hep-G2, MCF-7, HCT-116 and HELA cell lines with IC 50 of 12.1, 30.9, 11.7 and 19.5 µg/mL respectively compared and doxorubicin as a reference drug. Weak antiviral activity was seen against hepatitis A virus (HAV) and no impact against herpes simplex virus type 1 (HSV 1).
Introduction
The Asteraceae (Compositae) is the biggest family of flowering plants with more than 24000 -30000 species and 1600 -1700 genera, distributed worldwide aside from Antarctica with an observable financial and medicinal contribution (Funk et. al, 2005) .
Centaurea, the fourth biggest genus in the family Asteraceae, consists of 600 species around the world, especially in Mediterranean regions and in Western Asia, (Garcia-Jacas et al, 2000). Around 13 species of Centaurea are growing in Egypt. Centaurea species, have been the object of various phytochemical studies, with a diversity of bioactive phytochemicals and prevalence of flavonoids (Flamini et al., 2001; Shoeb et al., 2007; Seghiri et al, 2009 ) and sesquiterpene lactones . Centaurea species are claimed for their uses in gastrointestinal and inflammatory disorders, hypotensive and cytotoxic activities, in addition to the anti-bacterial impacts alone or when mixed with different plants (Farrag et al., 1993; Kargıoglu et al, 2010 ; Köse et al., 2007) . Centaurea aegyptiaca (Centaurea cancellata Sieber ex Spreng., Calcitrapa aegyptiaca (L.) Sweet, C. iberica) is growing wild in Sinai (St. Katherine), Egyptian eastern desert, the Red Sea coastal strip, and Gebel Elba. Investigations of C. aegyptiaca revealed the presence of guaianolide which showed potential cytotoxic activities against liver and larynx carcinoma cell lines. The studies on this species deal basically with sesquiterpene lactones, while flavonoids are not well investigated.
Due to scarcity of information regarding the chemical composition of C. aegyptiaca, it is valuable to carry out an in-depth phytochemical investigation on this plant to characterize its main active constituents utilizing HPLC-MS-MS analysis and Xcalibur software with the screening of its cytotoxic and antiviral activities.
Plant Material
Aerial parts of Centaurea aegyptiaca L. were gathered during the flowering stage in February 2015 from km 67, CairoSuez road, Egypt. The plant was identified by Prof. Dr. Abdel-haleem Abdel-mogaly, Department of Plant Taxonomy, Herbarium of Horticultural Research Institute, Agricultural Research Center, Dokki, Cairo, Egypt. A voucher specimen (RS013) was deposited in Herbarium of Faculty of Pharmacy, October University of Modern Sciences and Arts.
Material and Methods

Preparation of the plant extract
Three hundred grams of plant material were exhaustively extracted with methanol. The combined methanolic extracts (CME) were filtered, concentrated under vacuum at 50°C, dried and left for LC-HRESI-MS-MS analysis, and to evaluate the cytotoxic and antiviral activities.
Cytotoxic activity
The viability of control and treated cells were explored at the Regional Center for Mycology and Biotechnology (RCMB) at Al-Azhar University. The CME was tested against the following human tumor cell lines: hepatocellular carcinoma (HepG-2), breast adenocarcinoma (MCF-7), colorectal carcinoma (HCT-116), cervix adenocarcinoma (HELA) utilizing MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) test in triplicate (Fotakis and Timbrell, 2006) . Untreated cells represented the negative control while doxorubicin was the positive control. The absorbance was measured at 570 nm using a microplate ELISA reader (Sun Rise TECAN, Inc, USA). The absorbance of untreated cells was considered as 100%. The results were determined by three independent experiments (Wilson, 2000) .
The percentage cell viability was calculated with the Microsoft Excel®. Percentage cell viability was calculated as follows: % Cell viability = (Mean Abs control -Mean Abs test metabolite X 100)/ Mean Abs control Where: Abs: absorbance at 570 nm
The graphic plots were used for estimation of the 50% inhibitory concentration (IC 50 ). STATA statistical analysis package was used for the dose response curve drawing in order to figure IC 50 .
Antiviral activity
Cytopathic effect inhibition assay was performed following Hu and Hsiung, (1989) . The cultures were treated with two fold serial dilutions of C. aegyptiaca extract. Six wells were utilized for every concentration of C. aegyptiaca extract. Untreated vero cells in absence of CME represented the control. Inverted microscope was used for watching the virus in the control wells every 24hr until complete viral-induced cytopathic effects (CPE). Antiviral activity was evaluated by the inhibition of cytopathic effect in comparison with control where scoring of the protection level offered by Centaurea extract was estimated (Vijayan et al., 2004) . The experiment was performed thrice. Acyclovir, the treatment clinically used for herpetic viral disease, was utilized as a positive control (Dargan, 1998) .
LC-HRESI-MS-MS apparatus
The study was performed on a Bruker micro-TOF-Q Daltonics (API) Time-of-Flight mass spectrometer (Bremen, Germany), coupled to 1200 series HPLC system (Agilent Technologies, Waldbronn, Germany), equipped with a high-performance auto-sampler, binary pump, and PDA detector G 1314 C (SL). Chromatographic separation was performed on a Superspher 100 RP-18 (75 × 4mm i.d.; 4 m) column (Merck, Darmstadt, Germany). 
Identification of Phenolic Compounds
Centaurea aegyptiaca CME was investigated following Hassaan et al, (2014) . The mobile phase consists of two solvents, (A) 2% acetic acid (pH 2.6) and (B) 80% methanol. Gradient elution was used at a flow rate of 100 L/min, from 5% to 50% B at 30°C. Ion spray (pneumatically assisted electrospray) ionization system was utilized. Spectra were recorded in positive and negative ion mode between m/z 120 and 1,500 with capillary voltage, 4000V and heated dry nitrogen gas temperature, 200°C and flow rate 10 L/min. The gas flow to the nebulizer was set at pressure 1.6 bar. For collision-induced dissociation (CID) MS-MS estimations, the voltage over the collision cell ranged between 20 to 70 eV. Argon was utilized as collision gas. Sodium formate was utilized for calibration toward the end of LC-MS run. Interpretation for ESI-MS was performed by Xcalibur 2.1 software from Thermo Scientific (Berlin, Germany).
Results
Phenolics identified
The phytochemical fingerprint of C. aegyptiaca was determined using an LC-HRESI-MS-MS. Analyses were carried out by using a full scan and MS2 data-dependent operative mode.
The combination of ESI positive and negative modes permitted the tentative identification of a total of sixty-one compounds by the interpretation of their fragmentation patterns combined with the available literature information. Twenty-one phenolic acid and their derivatives have been identified in the negative mode only (Table 1) , while thirty-one flavonol and nine flavones were tentatively identified based on their MS/MS fragmentation in the negative and positive modes and listed in table 2.
Cytotoxic activity
Centaurea aegyptiaca CME was investigated against four human cell carcinoma (HepG-2, MCF-7, HCT-116, and HELA) using MTT assay. The higher potency was observed with HCT-116 followed by HepG-2 then HELA cells (Table 3) with IC 50 less than 20 µg/mL compared with doxorubicin as a standard cytotoxic agent with a range of 0.46-0.23 µg/mL. 
Antiviral activity
Centaurea aegyptiaca CME exhibited weak antiviral activity against hepatitis A virus (HAV), and no effect was observed with herpes simplex virus type 1(HSV 1).
Discussion
Liquid chromatography/tandem mass spectrometry (LC/MS/MS), represents the most popular technique used to unravel the complexity of phenolic compounds. Those non-volatile, polar and thermally labile compounds are found as complex mixtures in plants . Centaurea aegyptiaca has not been studied for its phenolic content before.
Phenolic acids and their derivatives
Chlorogenic acids (CGAs) are a group of esters formed between a quinic acid and certain trans-cinnamic acids, most commonly caffeic, p-coumaric, and ferulic acid (Clifford et al, 2006) . 
Cytotoxic activity
When the IC 50 value in carcinoma cells, after incubation between 48 and 72 hrs, is under 20 μg/mL, the cytotoxic activity was commonly considered (Boik, 2001) . C. aegyptiaca CME demonstrated significant activity against colorectal and hepatocellular carcinoma. This promising cytotoxic action was related to the increased number of OH groups and presence of 3'-OMe as reported by Jeong 
Conclusion
Centaurea aegyptiaca is a rich source of phenolic and flavonoid glycosides contributing to a powerful cytotoxic activity that may represent a good candidate for further studies and reflects its traditional uses.
